|
Our Mission
We develop medicines that boost the patients' own immune system to live a longer and better life and change the treatment paradigm in the field of chronic infections, cancer and allergy.
Our Company
Genetic Immunity is a privately held US / Hungarian clinical-stage biotechnology company focusing on the discovery, development and commercialization of personalized Immune Therapies (Therapeutic Vaccines). Our Products are designed to boost specific immune responses to modify or control these presently incurable diseases. more»
ISO 9001:2008
Genetic Immunity has been certified for Biotechnological product development: research and development, clinical trials. more»
|
|
|
Latest Press Release
|
|
|
News Highlights
|
|
» January 25, 2012
LiveScience: New Vaccine Approach Gives Hope to Those Living with HIV
» November 03, 2011
Figyelô: "NANO-SUCCESS" in Hungary
» November 02, 2011
Digital Personal Medicine
» November 01, 2011
Structure and biological activity of pathogen-like synthetic nanomedicines
|
|
Platform Highlights
 » Clinical Studies with DermaVir
Our first Phase II study reached the primary endpoint and shows excelent safety, tolerability and preliminary efficacy... more»
 » DermaPrep Medical Device
CE Mark was obtained for our DermaPrep transdermal delivery device ... more»
 » Nanomedicine
Our Nanomedicine Antigen Composition technology creates pathogen-like nanoparticles from antigens. more»
 » ANTIGENeering
Our single pDNA API expresses several antigens and VLP+. more»
|
